Hadean Venture’s Annual Event
Oslo , NorwayIn October, Abliva's CEO, Ellen Donnelly, will attend Hadean Venture's annual event in Oslo.
Delivering mitochondrial health
In October, Abliva's CEO, Ellen Donnelly, will attend Hadean Venture's annual event in Oslo.
This fall, Abliva's CEO, Ellen Donnelly will attend the two connected events LSX Inv€$tival Showcase and Jefferies London Healthcare Conference. On November 13 at 11:45 a.m., the Abliva's CEO, Ellen […]
In late November, Abliva will attend Nordic Life Science Days, at Bella Center in Copenhagen, Denmark. CEO Ellen Donnelly will be presenting the company during the session Biotechnology - Therapeutics […]
In early January 2024, Abliva's CEO, Ellen Donnelly, will attend the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, USA. The conference is a healthcare investment symposium that connects […]
In mid-April, Abliva will participate at Kempen Life Sciences Conference in Amsterdam, The Netherlands. For more information, please click the link below.
In mid-May, Abliva will travel to the Bio€quity Europe meeting in San Sebastán, Spain. "For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, […]
Join Abliva for a virtual KOL event featuring Amel Karaa, MD (Massachusetts General Hospital), who will discuss the unmet medical need and current treatment landscape for patients with primary mitochondrial […]
In early November, Abliva's CEO, Ellen Donnelly, will attend the BIO-Europe meeting in Stockholm, Sweden. On Monday, November 4, Ellen will be presenting the company at 4:30 p.m. CET. Follow […]